DELIVERING TOMORROW’S
MED-TECH SYSTEMS Nolato is a global leading partner in the development and manufacture ofcustomer-specific medical devices, mobile phone components and specialist packaging products. Philip Yorke spoke to Christer Wahlquist, the company’s president of Nolato Medical, about its focus on meeting the future challenges facing the pharmaceutical industry and its continuing investment in the world’s fastest growing markets.
N
olato Medical forms a major part of the Nolato Group’s business activities and specialises in the development and manufacture of polymer components and devices for the pharmaceutical and Medical device industry. The Nolato Group was founded in Sweden in 1938 as Nordiska Latexfabriken i Torekov AB and operated under the trademark Nolato, which remains its trading name today. The group is divided into three distinct business divisions: Nolato Medical (medical devices and pharmaceutical packaging); Nolato Telecom (components and subsystems for mobile phones); and Nolato Industrial (for the development and manufacture of components for the automotive, forestry, white goods and packaging industries). Today Nolato is a major global player in its chosen disciplines and is headquartered in Torekov, Sweden, with production facilities located in Sweden, UK, Hungary, Romania, China, the USA and Malaysia. In addition, the company has sales offices in France, Germany, Taiwan and the Czech Republic. The Nolato Group employs more than 8000 people worldwide and in 2014 recorded sales of more than €460 million. The company is also quoted on the NASDDAQ OMX Nordic market stock exchange.
160 Industry Europe
